Serdexmethylphenidate Granted Orphan Drug Status for Idiopathic Hypersomnia

The FDA has granted Orphan Drug designation to serdexmethylphenidate (KP1077) for the treatment of idiopathic hypersomnia.

Related Keywords

Travis Mickle ,Drug Administration ,Orphan Drug ,